CN103652159A - Tea bag for preventing and treating hyperlipidemia diseases - Google Patents

Tea bag for preventing and treating hyperlipidemia diseases Download PDF

Info

Publication number
CN103652159A
CN103652159A CN201310530015.4A CN201310530015A CN103652159A CN 103652159 A CN103652159 A CN 103652159A CN 201310530015 A CN201310530015 A CN 201310530015A CN 103652159 A CN103652159 A CN 103652159A
Authority
CN
China
Prior art keywords
preventing
tea bag
health
treating
tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310530015.4A
Other languages
Chinese (zh)
Inventor
张新宇
王惠
王洪亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANHUI BOGE BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Original Assignee
ANHUI BOGE BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANHUI BOGE BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd filed Critical ANHUI BOGE BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201310530015.4A priority Critical patent/CN103652159A/en
Publication of CN103652159A publication Critical patent/CN103652159A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a tea bag for preventing and treating hyperlipidemia diseases and belongs to the field of health-keeping and health-caring tea bags. The tea bag for preventing and treating the hyperlipidemia diseases is mainly prepared from following components: 3.0g-8.0g of crataegus pinnatifida bunge, 1.0g-4.0g of ginkgo leaves, 0.5g-1.5g of prepared fleece flower roots, 0.2g-0.8g of semen cassiae, 0.1g-0.5g of lotus leaves and 0.1g-0.3g of monascus. The tea bag for preventing and treating the hyperlipidemia diseases can be used as health-care tea to be drunk usually; the tea bag is convenient and sanitary to drink, does not generate side effects and has a very good effect on preventing and treating hyperlipidemia; the possibility of the hyperlipidemia diseases can be greatly reduced after the tea bag is drunk usually.

Description

A kind of bubble bag agent that prevents and treats hyperlipidaemic conditions
Technical field:
The present invention relates to the agent of a kind of health care bubble bag, relate in particular to a kind of bubble bag agent that prevents and treats hyperlipidaemic conditions.
Background technology:
The agent of bubble bag is bubble tea bag, generally has the effect of health care, therefore be called health preserving tea or health protection tea, Chinese health protection tea, is to take herbal medicine as raw material,, containing tealeaves, does not only use " tea " this title.China health protection tea has the effect that reduces blood fat, cholesterol, to patients such as obesity, diabetes, hypertension, coronary heart disease, is a kind of auxiliary health drink.
Health protection tea is as beverage, and that it is faced is the crowd of various all ages and classes, sex, work, physique, and the number of its amount of drinking cannot be confined.As health protection tea, people can be the needs that quench one's thirst, and to human body, supplement moisture content, should also provide useful nutriment, play the effect of health care.The formulation of health protection tea is also diversified, is first health, safety; Next is nutrition and health care.Therefore, guaranteeing, under the prerequisite of safety and sanitation, must there is certain health care to human body.
Summary of the invention:
The object of this invention is to provide a kind of bubble bag agent that prevents and treats hyperlipidaemic conditions.
Technical problem to be solved by this invention realizes by the following technical solutions.
Prevent and treat a bubble bag agent for hyperlipidaemic conditions, it is characterized in that, mainly by following component, made:
Figure BDA0000405915300000011
The preferred group component of each component is:
Figure BDA0000405915300000021
The invention has the beneficial effects as follows:
The bubble bag agent of control hyperlipidaemic conditions provided by the invention, can be used as health protection tea and often drinks, and drinks convenient, healthyly, can not have side effects, and prevention and treatment high fat of blood are had to good effect, often drinks and can greatly reduce the probability of suffering from hyperlipidaemic conditions.
The specific embodiment:
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
3.0g ginkgo leaf 1.0g RADIX POLYGONI MULTIFLORI PREPARATA 0.5g is looked on mountain
Cassia seed 0.2g lotus leaf 0.1g red colouring agent for food, also used as a Chinese medicine 0.1g
Make according to a conventional method bubble bag.
Embodiment 2
8.0g ginkgo leaf 4.0g RADIX POLYGONI MULTIFLORI PREPARATA 1.5g is looked on mountain
Cassia seed 0.8g lotus leaf 0.5g red colouring agent for food, also used as a Chinese medicine 0.3g
Make according to a conventional method bubble bag.
Embodiment 3
5.5g ginkgo leaf 2.5g RADIX POLYGONI MULTIFLORI PREPARATA 1.0g is looked on mountain
Cassia seed 0.5g lotus leaf 0.3g red colouring agent for food, also used as a Chinese medicine 0.2g
Make according to a conventional method bubble bag.
The present invention carries out tracking test to 150 healthy populations, the male sex's 80 examples wherein, and women's 70 examples, the mean age is 45 years old, maximum 65 years old, minimum 40 years old.Often drink the agent of bubble of the present invention bag, after 5 years, in 150 people, be examined people's 6 examples only of suffering from hyperlipidaemic conditions, well below the average P of hyperlipidaemic conditions, prove that often drinking a bubble of the present invention bag agent has good prevention effect to hyperlipidaemic conditions.
150 routine hyperlipidaemic conditions patients are followed the tracks of to treatment, the male sex's 80 examples wherein, women's 70 examples, the mean age is 55 years old, maximum 73 years old, minimum 45 years old.Often drink bubble bag of the present invention agent, wherein have the 61 routine state of an illness to take a turn for the better to some extent, 52 examples have obvious rehabilitation efficacy, and 37 routine DeGrains prove that often drinking bubble bag of the present invention agent has good result for the treatment of to hyperlipidaemic conditions patient.
Model case:
Example one, Zhang, 52 years old, female, teacher, inspection in 2012 suffers from high fat of blood, undesirable through result for the treatment of.Often drink after bubble of the present invention bag agent half a year, situation obviously improves.
Example two, grandson, man, 49 years old, company personnel, dinner party is at ordinary times many, does not get enough athletic exercise again, within 2012, checks and suffers from high fat of blood.Often drink after bubble bag of the present invention agent, the state of an illness alleviates gradually.
More than show and described basic principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that in above-described embodiment and description, describes just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.

Claims (2)

1. prevent and treat a bubble bag agent for hyperlipidaemic conditions, it is characterized in that, mainly by following component, made:
2. the bubble bag agent of control hyperlipidaemic conditions according to claim 1, is characterized in that, the preferred group component of each component is:
CN201310530015.4A 2013-10-31 2013-10-31 Tea bag for preventing and treating hyperlipidemia diseases Pending CN103652159A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310530015.4A CN103652159A (en) 2013-10-31 2013-10-31 Tea bag for preventing and treating hyperlipidemia diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310530015.4A CN103652159A (en) 2013-10-31 2013-10-31 Tea bag for preventing and treating hyperlipidemia diseases

Publications (1)

Publication Number Publication Date
CN103652159A true CN103652159A (en) 2014-03-26

Family

ID=50291877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310530015.4A Pending CN103652159A (en) 2013-10-31 2013-10-31 Tea bag for preventing and treating hyperlipidemia diseases

Country Status (1)

Country Link
CN (1) CN103652159A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105054015A (en) * 2014-08-07 2015-11-18 李汉臣 Traditional Chinese medicine "San Su Yi Fen" cell protective long-life three-five combination novel medical skill
CN105853795A (en) * 2016-05-13 2016-08-17 新乡医学院 Bag-packed preparation with cerebrovascular disease rehabilitation effect

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857475A (en) * 2006-04-07 2006-11-08 毛晓敏 Composition for preventing and treating cardias and cerebral vascular diseases and its application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1857475A (en) * 2006-04-07 2006-11-08 毛晓敏 Composition for preventing and treating cardias and cerebral vascular diseases and its application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
无: "山楂荷叶决明茶", 《360DOC个人图书馆》, 11 March 2012 (2012-03-11) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105054015A (en) * 2014-08-07 2015-11-18 李汉臣 Traditional Chinese medicine "San Su Yi Fen" cell protective long-life three-five combination novel medical skill
CN105054015B (en) * 2014-08-07 2018-09-14 李汉臣 A kind of raspberry Chinese medicine superfine powder combination novel formulation that lengthens one's life rich in natural three element
CN105853795A (en) * 2016-05-13 2016-08-17 新乡医学院 Bag-packed preparation with cerebrovascular disease rehabilitation effect

Similar Documents

Publication Publication Date Title
Yusof et al. Use of complementary and alternative medicine in pregnancy and its impact on obstetric outcome
CN103609766B (en) Tea bag capable of slimming, maintaining beauty, and keeping young
CN104256600B (en) Health nutrient composition and method of making the same and application
CN101564070A (en) Natural qi invigorating and lung moistening tea and processing method
CN104082465A (en) Tea for regulating ovarian cancer
CN104782833A (en) All-season health tea and preparation method thereof
CN103652159A (en) Tea bag for preventing and treating hyperlipidemia diseases
CN103609767A (en) Tea bag having slimming and fat-reducing function
CN104587339A (en) Traditional Chinese medicine soaking agent for treating chemotherapy-related peripheral nerve toxicity
CN104107264A (en) Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent
CN103609765A (en) Bagged preparation for preventing and treating hypertension disease
CN106491738A (en) A kind of Chinese medicine composition for treating cervical spondylopathy
CN106359726A (en) Health-care health-preserving tea capable of reinforcing kidney, supporting yang, benefiting eyes and improving eyesight
CN103609787A (en) Tea bag helping to recuperate from cardio cerebrovascular disease
CN103609791B (en) Tea bag capable of increasing brain function and improving memory
CN104957703A (en) Anti-alcoholism beverage and manufacturing method thereof
CN104814195A (en) Vitality strengthening tea
CN104352669B (en) A kind of application of Chinese medicine in weak sperm disease is treated
CN103609790B (en) Tea bag capable of enhancing immunization and preventing disease
CN107980988A (en) Speen-kidney dificiency health preserving tea and preparation method thereof
CN103609788A (en) Tea bag capable of enriching yin and nourishing kidney as well as invigorating yang
CN102450350A (en) Intestinal tract cleaning tea
CN103609768A (en) Tea bag capable of preventing common gynopathy and osteoporosis
CN106343094A (en) Healthcare tea for strengthening waist and knee and benefiting essence and blood
CN103609789A (en) Tea bag capable of preventing cardio cerebrovascular disease

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326